LifeWatch wins FDA 510(k) clearance for vital sign monitoring

by Fink Densford for MassDevice

Swiss remote diagnostic monitoring company LifeWatch said today it received FDA 510(k) clearance for its Vital Signs monitoring service.

The service operates using wireless, patch-based vital signs monitors to allow for early detection of vital signs to enable more timely interventions, which the company claims leads to increased nursing efficiency and higher patient satisfaction.

“This clearance represents another significant technological breakthrough for LifeWatch and further strengthens our position as an innovational leader in digital health. I am highly excited at the tremendous market potential for the easy-to-use Vital Signs Patch, both in the clinical and ambulatory settings worldwide. Furthermore, the cost benefits will allow vital signs monitoring to be utilized for a much broader patient population. However, providing service in a clinical environment is a new market for LifeWatch and will therefore require both time and additional resources in order to ensure a successful market launch,” CEO Dr. Stephan Rietiker said in prepared remarks.

The Vital Signs patches are cable-free sensors worn on a patient’s upper chest, and intended for use by adult patients in clincial environments for continuous, non-invasive monitoring of ECG, heart rate, respiration rate, surface temperature, arterial blood oxygen saturation and body position, the company said. The patch will be released in 2 versions, with or without ECG.

The company said it plans to offer the system initially to medical facilities, following with the larger ambulatory market once the tech has been “proven in the clinical environment.”

Save time with kBLASTER's unique result management features of sorting, My Favorites, Saved Search and Search History from a web browser, so either mobile devices or computers can be used to quickly find your primary predicate, multiple predicates or reference devices to build a successful 510(k) clearance strategy. Save money in your 510(k) regulatory strategy and follow-on 510(k) submission spend by enabling self-service extraction of actionable insight from nearly 63,000 FDA medical device 510(k) clearance summaries, plus more than 76,000 splash pages for a total more than 139,000 records.